Public Health Agency of Barcelona
14
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Implementing an Adapted Smoke-free Homes Intervention in Spain
Role: collaborator
Development and Evaluation of Virtual Reality Experiences for Cognitive Stimulation at the Sociosanitary Center El Carme
Role: collaborator
Effectiveness of an Intervention on Vaccine Hesitancy Among Pediatric Nurses and Pediatricians
Role: collaborator
Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco Use
Role: collaborator
The Impact of Air Pollution on the Consumption of Antimicrobials in the General Population
Role: collaborator
MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain
Role: collaborator
Tobacco Cessation Among Smokers Under Alcohol and/or Cannabis Treatment
Role: collaborator
Tuberculosis In Children Visiting Friends and Relatives
Role: collaborator
Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home
Role: collaborator
Environmental Assessment of Secondhand Smoke Exposure in Private Settings and Outdoor Settings in Europe
Role: collaborator
Impact of Secondhand Exposure to E-cigarettes Aerosols on the Respiratory System
Role: collaborator
Community Intervention to Reduce Social Isolation in Elderly People: a Mixed Methods Multi-approach Evaluation
Role: lead
Impact of Alcohol Consumption on Use of Health Care Resources
Role: collaborator
An Integrated Intervention to Reduce Secondhandsmoke in Children
Role: collaborator
All 14 trials loaded